Study: Many cancer drugs remain unproven after accelerated approval

Drugs that got accelerated approval may be the only option for patients with rare or advanced cancers.

Related Keywords

Michigan ,United States ,Houston ,Texas ,San Diego ,California ,American ,Edward Cliff ,Jennifer Litton ,Cherie Duvall Jones ,Ezekiel Emanuel ,Md Anderson Cancer Center ,University Of Pennsylvania ,Drug Administration ,Harvard Medical School ,Journal Of The American Medical Association ,American Association For Cancer Research ,Scripps News Propublica ,American Medical Association ,American Association ,Cancer Research ,Harvard Medical ,Cancer Center ,